BMS and Novartis Provide Unrestricted Grants to Social Media Initiatives

by shwen Add comments


According to the
Pharma 2.0 Blog, “Bristol-Myers Squibb provided unrestricted funding to facilitate the launch of a new site for women with advanced breast cancer“.

The Advanced Breast Cancer Community launched in early September offering both an information gateway and social network for the advanced/metastatic breast cancer community…
As one user commented, “Early on in my diagnosis I perused many Internet sites that just left me more confused, scared and depressed than I already was. So I gave up looking. Until something brought me to this site just yesterday. What a great place. I can tell already that this is the place where I want to hang out.”

The site was built by Inspire which “…builds and manages online communities in which thousands of patients, family members and caregivers support and communicate with one another in safe, secure, privacy- protected environments“.

Most Inspire communities are built for free and operate under the auspices of some of the most respected nonprofit health organizations in the US. Our nonprofit partners include such distinguished organizations as the ALS Association, Arthritis Foundation, Lung Cancer Alliance, National Organization of Rare Disorders, and the National Osteoporosis Foundation, among others.

I think it’s a really good sign that pharmaceutical companies are starting to recognize the value and importance that online communities and other social media efforts can have in supporting patients, caregivers, and even healthcare professionals.

In fact, this isn’t first unrestricted grant that I’ve heard of from a pharma company to a non-profit social media initiative. Just a few weeks ago at the Digital Pharma conference, I was speaking with Matt Zachary — Founder and CEO of I’m Too Young For This (i2y) — who told me that Novartis Oncology had provided an unrestricted grant to them for their on and off -line initiatives that support young adults affected by cancer. Looks like they also got support from MGI Pharma, GSK, Schering-Plough and a bunch other non-pharma related organizations (including Heineken!!!).

Here’s a list of various i2y programs that tries to help “empower young adults affected by cancer by ending isolation, improving quality of life and providing meaningful survivorship“:

Considering that the i2y slogan and campaign is “Stupid Cancer”, you would think that traditionalists would exclude them from funding or even a consideration just by the mere fact that it’s not titled something more “professional” or that many of their efforts are based in social media. So I’m really glad to see that neither the social media aspect nor the slogan has turned off support for this truly important network — well done to the funding bodies for not letting these issues get in the way of initiatives that really work and really support a good cause!

  • Share/Bookmark

7 Responses to “BMS and Novartis Provide Unrestricted Grants to Social Media Initiatives”

  1. Amy Says:

    I am the co-regional chair for I2Y in Florida. Thank you so much for helping us get the word out about I2Y!

  2. Kairol Rosenthal Says:

    Cancer is stupid, but the folks at pharma are no dummies. Matthew Zachary’s audience, as well as the readers of my book (Everything Changes: The Insider’s Guide To Cancer In Their 20’s and 30’s), are ripe targets for online medical marketing. The Pew Internet and American Life Project shows that young adults more than any other age show benefit from seeking online health information. Pharma funds cancer conferences and cancer support groups; social networking for patients is a logical extension of these programs. Open the flood gates.

  3. shwen Says:

    Amy, You are most welcome – always glad to help out a good cause, especially one that uses social media! :-) Will have to get Matt on a Med 2.0 podcast interview soon!

  4. shwen Says:

    Kairol,
    Thanks for your comment – I totally agree with you, but as you know, Pharma has always been a slow adopter and cautious with where they dip their toes, especially if they feel like they cannot control the medium. However, it only makes sense to “fish Where the Fish Are” (like Chris Brogan’s eBook says).

  5. Pharma Marketing this week « Impactiviti blog Says:

    [...] and Novartis provide unrestricted grants for social media initiatives – full story here This is great news, and I think the most effective way pharma companies can start dabbling in [...]

  6. Pharma Blog Review » Blog Archive » A new president, a look at the future, but the world goes on Says:

    [...] the Med 2.0 blog comes the news that Bristol-Myers Squibb and Novartist have provided unrestricted grants for social media initiatives, aimed at cancer patients. (Hat tip to Steve Woodruff of Impactiviti.) About the Bristol-Myers [...]

  7. Brad at Pharma Says:

    Shwen,

    Thanks for capturing this for us. It’s nice to hear about initiatives that my company is involved in… from outside my company :) … It’s good to see that the unrestricted grants are helping kick start the SocMedia environment.

    Now, to track down the legal folks to see what kind of Adverse Event (AE) Reporting responsibility we have to assume with this… This seems to be the stumbling block in many of the discussions I’ve read. AEs. How do we report them? How do we track them? How do we maintain compliance with the FDA safety regulations? I know there are some tools out there, and now I’m wondering if we’re using them in this case… off to hunt people, now…

    FULL DISCLOSURE : #iwork@novartis I work for Novartis Pharmaceuticals

Leave a Reply

WP Theme & Icons by N.Design Studio
Entries RSS Comments RSS Log in